RED-FPT

Red-Shifted Fluorescence Protein Tomography

Coordinatore	HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH    more  Organization address address: Ingolstaedter Landstrasse 1 city: MUENCHEN postcode: 85764 contact info Titolo: Mr. Nome: Juergen Cognome: Ertel Email: send email Telefono: +49 089 31873852 Fax: +490 89 31873017
Nazionalità Coordinatore	Germany [DE]
Totale costo	162˙096 €
EC contributo	162˙096 €
Programma	FP7-PEOPLE Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
Code Call	FP7-PEOPLE-2007-2-1-IEF
Funding Scheme	MC-IEF
Anno di inizio	2008
Periodo (anno-mese-giorno)	2008-09-01   -   2010-10-31

 Partecipanti

#	participant	country	role	EC contrib. [€]
1	HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH  Organization address address: Ingolstaedter Landstrasse 1 city: MUENCHEN postcode: 85764 contact info Titolo: Mr. Nome: Juergen Cognome: Ertel Email: send email Telefono: +49 089 31873852 Fax: +490 89 31873017	DE (MUENCHEN)	coordinator	0.00

Mappa

 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

 Obiettivo del progetto (Objective)

'The introduction of transgenes that express fluorescent proteins (FPs) into cells has revolutionized the ability to visualize many cellular and sub-cellular processes that are otherwise invisible with traditional means of optical imaging. Fluorescent proteins have been widely used in microscopic imaging, however deep tissue imaging has not been possible, before the recent development of fluorescent proteins emitting beyond the 600 nm absorption threshold. In the present proposal the applicant will study and develop a novel optical tomographic method for preclinical research applications with the use of the recently evolved red-shifted fluorescent proteins. The development is going to be based on modifying the existing Fluorescence Molecular Tomography method both in its experimental and theoretical part as necessary. The result will be a tomographic method and system that will be used to reconstruct in 3D the location of the fluorescent proteins deep inside the tissue of small animals (mice) with submillimeter resolution. The proposed method/system will be tested against various of the parameters of its operation and will be used to demonstrate its use in in-vivo biomedical imaging applications. A method/system like the proposed has the potential to become a high capability non invasive monitoring and diagnostic tool in bio-medical research on small animals.'